Compliance Rate
Compliance Rate
100.0%
Compliant submissions
4
Incompliant submissions
0
Total trials
4
My Organizations' Clinical Trials
Showing 525 of 1353 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/03/25
End: 07/30/26
Due: 07/30/27
Phase: N/A
Priority: Normal
Start: 07/29/21
End: 03/01/23
Due: 03/01/24
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 06/30/99
End: 09/30/05
Due: 09/30/06
Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates
Phase: N/A
Priority: Normal
Start: 12/31/06
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 08/22/22
End: 08/31/26
Due: 08/31/27
Phase: N/A
Priority: Normal
Start: 04/06/17
End: 09/05/22
Due: 09/05/23
Phase: N/A
Priority: Normal
Start: 03/31/95
End: 04/30/02
Due: 04/30/03
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 08/31/06
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 09/30/99
End: 09/30/01
Due: 09/30/02
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 03/31/05
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 09/30/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/02/21
End: 01/22/24
Due: 01/22/25
Phase: N/A
Priority: Normal
Start: 01/31/04
End: 01/30/18
Due: 01/30/19
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 05/02/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/28/25
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 04/29/21
Due: 04/29/22
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 03/31/05
End: 05/31/05
Due: 05/31/06
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 08/31/16
Due: 08/31/17